超高分辨率双源光子计数CT多发性骨髓瘤成像模式
回顾性纳入84例患者(53例初治多发性骨髓瘤、31例前驱状态),行全身双源光子计数CT,在70与40 keV虚拟单能图像上测量溶骨性病变及股骨骨髓CT值。结果显示多发性骨髓瘤存在软组织衰减型、脂肪衰减型及混合型三种影像表型,脂肪衰减型未被现行IMWG局灶性病变定义覆盖。
要点
- 脂肪衰减型溶骨病变符合症状性骨病但不在现行IMWG局灶性病变定义内
- 股骨骨髓以假结节型最常见,骨髓脂肪型在前驱状态中占58.1%
- 骨内膜扇贝样改变仅见于溶骨性多发性骨髓瘤(18.9%)
核心结论
- DS-PCCT识别出既往未被描述的多发性骨髓瘤脂肪衰减为主影像表型,该表型符合症状性骨病标准但不被现行IMWG局灶性病变定义覆盖。
- 骨髓受累的光谱-形态学表征可补充现有影像标准,有助于鉴别显性多发性骨髓瘤与非特异性骨髓异常。
研究设计与样本
- 由3名委员会认证放射科医师在70与40 keV虚拟单能图像上测量溶骨性病变和股骨骨髓CT衰减值。
- 长骨评估弥漫高级别、结节型、假结节型、脂肪骨髓型模式及骨内膜扇贝样改变,参考标准为临床诊断。
关键影像表现/征象
- 53例多发性骨髓瘤中40例(75.5%)光谱-形态学分析识别出3种患者水平溶骨性骨病影像表型。
- 软组织衰减型25例(47.2%)、脂肪衰减型10例(18.9%)、两种病变共存5例(9.4%)。
- 假结节型为股骨骨髓最主要影像模式,脂肪骨髓型占30.2%,结节型占18.9%,弥漫高级别浸润占3.8%。
- 前驱状态主要表现脂肪型(58.1%)和假结节型(38.7%)骨髓模式,低keV虚拟单能图像显示各模式具有不同能量依赖性衰减。
诊断标准与关键数值
- 骨内膜扇贝样改变仅见于溶骨性多发性骨髓瘤,发生率为18.9%。
- 不同骨髓模式在低keV虚拟单能图像上表现出随能量变化的衰减特征,CT值测量观察者间一致性ICC大于0.82。
- 脂肪衰减型溶骨病变符合症状性骨病标准,但现行IMWG局灶性病变定义未覆盖该类型。
临床应用与阅片要点
- 阅片时应同时观察溶骨性病变的软组织与脂肪衰减特征,避免将脂肪衰减型病变误判为良性。
- 股骨骨髓假结节型常见于多发性骨髓瘤,需结合骨内膜扇贝样改变与局灶性溶骨病变综合判断。
- 前驱状态以脂肪型和假结节型骨髓为主,出现弥漫高级别浸润或结节型时应警惕向显性骨髓瘤转化。
局限性
- 回顾性单中心研究设计。
- 样本中前驱状态组患者数量少于多发性骨髓瘤组。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
RATIONALE AND OBJECTIVES: Dual-source photon-counting CT (DS-PCCT) combines spectral imaging with ultra-high spatial resolution for whole-body assessment of multiple myeloma (MM). This study assessed axial and appendicular skeletal manifestations at initial diagnosis by exploiting attenuation characteristics of soft tissue and fat in low-keV virtual monoenergetic images (VMI).
MATERIALS AND METHODS: In this retrospective study, 84 patients (67.1±10.5 y, 54 men) underwent whole-body DS-PCCT between November 2024 and December 2025. The sample comprised 53 therapy-naïve MM patients and 31 with precursor conditions (monoclonal gammopathy of undetermined significance, smoldering myeloma, solitary plasmacytoma). Three board-certified radiologists measured CT attenuation of osteolytic lesions and femoral bone marrow at 70 and 40 keV. Long bones were evaluated for diffuse high-grade, nodular, pseudonodular, and fatty marrow patterns, as well as endosteal scalloping.
RESULTS: Among 53 MM patients, 40 (75.5%) spectral-morphologic analysis identified 3 patient-level imaging phenotypes of osteolytic bone disease: a soft-tissue-attenuation phenotype (n=25, 47.2%), a fat-attenuation phenotype (n=10, 18.9%), and coexistence of both lesion types (n=5, 9.4%). The pseudonodular pattern was the predominant femoral marrow imaging pattern, whereas fatty marrow (30.2%), nodular lesions (18.9%), and diffuse high-grade infiltration (3.8%) occurred less frequently. Endosteal scalloping occurred exclusively in osteolytic MM (18.9%). Precursor conditions mainly showed fatty (58.1%) and pseudonodular (38.7%) patterns. Low-keV VMI demonstrated distinct energy-dependent attenuation across patterns. Inter-reader agreement for Hounsfield unit measurements was good to excellent (ICC >0.82).
CONCLUSIONS: DS-PCCT identified a previously undescribed fat-attenuation-predominant imaging phenotype in MM that meets criteria for symptomatic bone disease but is not captured by current International Myeloma Working Group definitions of focal lesions. Spectral-morphologic characterization of marrow involvement may complement existing imaging criteria and aid differentiation between overt MM and nonspecific marrow abnormalities.
引用
- Heidemeier, Huflage, Rasche, et al. Ultra-High-Resolution Dual-Source Photon-Counting CT for Expanded Characterization of Pathophysiological Imaging Patterns in Multiple Myeloma. Invest Radiol. 2026. PMID: 42458991. doi:10.1097/RLI.0000000000001304
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。